Administration-Time-Dependent Effects of Doxazosin GITS on Ambulatory Blood Pressure of Hypertensive Subjects

References

• Anwar Y. A., Giacco S., McCabe E. J., Tendler B. E., White W. B. Evaluation of the efficacy of the Omron HEM-737 Intellisense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press Monit. 1998; 3: 261–265, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Calvo C., Hermida R. C., Ayala D. E., López J. E., Domínguez M. J., Covelo M., Mojón A., Fernández J. R. Time of administration versus increasing dose of doxazosin GITS for improved blood pressure control in patients with refractory hypertension. J. Hypertens. 2003; 21(suppl 4)S179
   PubMed Web of Science ®Google Scholar
• Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Rocella E. J. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560–2571, and the National High Blood Pressure Education Coordinating Committee[PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chung M., Vashi V., Puente J., Sweeney M., Meredith P. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation. Br. J. Clin. Pharmacol. 1999; 48: 678–687, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ebata H., Hojo Y., Ikeda U., Ishida H., Natsume T., Shimada K. Differential effects of an alpha 1-blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Hypertens. Res. 1995; 18: 125–130, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Elliott H. L., Meredith P. A., Vincent J., Reid J. L. Clinical pharmacological studies with doxazosin. Br. J. Clin. Pharmacol. 1986; 21: 27S–31S, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fernández J. R., Hermida R. C. Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 1998; 15: 191–204
   PubMed Web of Science ®Google Scholar
• Guidelines Committee. 2003 European Society of Hypertension—European Society of Cardiology guiudelines for the management of arterial hypertension. J. Hypertens. 2003; 21: 1011–1053
   PubMed Web of Science ®Google Scholar
• Hansson L., Hedner T., Dahlöf B. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Blood Press. 1992; 1: 113–119, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hermida R. C., Ayala D. E. Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension 2003; 42: 619–624, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hermida R. C., Ayala D. E., Fernández J. R., Mojón A., Alonso I., Calvo C. Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol. Int. 2002a; 19: 461–481, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hermida R. C., Calvo C., Ayala D. E., Fernández J. R., Ruilope L. M., López J. E. Evaluation of the extent and duration of the “ABPM effect” in hypertensive patients. J. Am. Coll. Cardiol. 2002b; 40: 710–717, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hermida R. C., Calvo C., Ayala D. E., Mojón A., López J. E. Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 2002c; 20: 1097–1104, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kario K., Schwartz J. E., Pickering T. G. Changes of nortunal blood pressure dipping status in hypertensives by nighttime dosing of α-adrenergic blocker, doxazosin. Results from the HALT study. Hypertension 2000; 35: 787–794, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kawano Y., Tochikubo O., Watanabe Y., Miyajima E., Ishii M. Doxazosin suppresses the morning increase in blood pressure and sympathetic nervous activity in patients with essential hypertension. Hypertens. Res. 1997; 20: 149–156, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Langner B., Lemmer B. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propanolol in healthy subjects. Eur. J. Clin. Pharmacol. 1988; 33: 619–624, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lehtonen A. Doxazosin effects on insulin and glucose in hypertensive patients. The Finnish Multicentre Study Group. Am. Heart J. 1991; 121: 1307–1311, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lemmer B. Cardiovascular chronobiology and chronopharmacology. Biologic Rhythms in Clinical and Laboratory Medicine, Y. Touitou, E. Haus. Springer-Verlag, BerlinGermany 1992; 418–427
   Google Scholar
• Lemmer B. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from the chronobiological point of view. Blood Press Monit. 1996; 1: 161–169, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Lemmer B., Nold G., Behne S., Kaiser R. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol. Int. 1991; 8: 485–494, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Linsell C. R., Lightman S. L., Mullen P. E., Brown M. J., Causon R. C. Circadian rhythms of epinephrine and norepinephrine in man. J. Clin. Endocrinol. Metab. 1985; 60: 1210–1215, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mansoor G. A., White W. B., McCabe E. J., Giacco S. The relationship of electronically monitored physical activity to blood pressure, heart rate, and the circadian blood pressure profile. Am. J. Hypertens. 2000; 13: 262–267, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Morgan T., Anderson A. Different drug classes have variable effects on blood pressure depending on the time of day. Am. J. Hypertens. 2003; 16: 46–50, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Morgan T., Anderson A., Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J. Hypertens. 1997; 15: 205–211, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Myburgh D. P., Verho M., Botes J. H., Erasmus Th.P., Luus H. G. 24-Hour pressure control with ramipril: comparison of once-daily morning and evening administration. Curr. Ther. Res. 1995; 56: 1298–1306, [CROSSREF]
   Web of Science ®Google Scholar
• Neaton J. D., Grimm R. H. Jr., Prineas R. J., Stamler J., Grandits G. A., Elmer P. J., Cutler J. A., Flack J. M., Schoenberger J. A., McDonald R. Treatment of mild hypertension study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993; 270: 713–724, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• O’Brien A., Asmar R., Beilin L., Imai Y., Mallion J. M., Mancia G., Mengden T., Myers M., Padfield P., Palatini P., Parati G., Pickering T., Redon J., Staessen J., Stergiou G., Verdecchia P., on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J. Hypertens. 2003; 21: 821–848, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• O’Brien E., Sheridan J., O’Malley K. Dippers and non-dippers. Lancet (letter) 1988; 13: 397
   Google Scholar
• O’Brien E., Staessen J. Normotension and hypertension as defined by 24-hour ambulatory blood pressure monitoring. Blood Press. 1995; 4: 266–282
   PubMedGoogle Scholar
• Ohkubo T., Hozawa A., Yamaguchi J., Kikuya M., Ohmori K., Michimata M., Matsubara M., Hashimoto J., Hoshi H., Araki T., Tsuji I., Satoh H., Hisamichi S., Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 2002; 20: 2183–2189, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Os I., Stokke H. P. Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertension. Blood Press. 1999; 8: 184–191, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Palatini P., Mos L., Motolese M., Mormino P., Del Torre M., Varotto L., Pavan E., Pessina A. C. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int. J. Clin. Pharmacol. Ther. Toxicol. 1993; 31: 295–300, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Palatini P., Racioppa A., Raule G., Zaninotto M., Penzo M., Pessina A. C. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin. Pharmacol. Ther. 1992; 52: 378–383, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Panza J. A., Epstein S. E., Quyyumi A. A. Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N. Engl. J. Med. 1991; 325: 986–990, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Pickering T. G., Levenstein M., Walmsley P. Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT study. Am. J. Hypertens. 1994; 7: 844–847, for the Hypertension and Lipid Trial Study Group[PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Pool J. L., Taylor A. A., Nelson E. B. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension. Am. J. Med. 1989; 87: 53S–56S, [CROSSREF]
   Web of Science ®Google Scholar
• Portaluppi F., Smolensky M. H. Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, W. B. White. Humana Press, Totowa, NJ 2000; 79–118
   Google Scholar
• Portaluppi F., Vergnani L., Manfredini R., degli Uberti E. C., Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am. J. Hypertens. 1995; 8: 719–726, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Smith D. H., Neutel J. M., Lacourciere Y., Kempthorne-Rawson J. Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. J. Hypertens. 2003; 21: 1291–1298, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Staessen J., Fagard R., Lijnen P., Thijs L., Vaa Hoof R., Amery A. Ambulatory blood pressure monitoring in clinical trials. J. Hypertens. 1991; 9(suppl 1)s13–s19
   Google Scholar
• Staessen J. A., Thijs L., Fagard R., O'Brien E. T., Clement D., de Leeuw P. W., Mancia G., Nachev C., Palatini P., Parati G., Tuomilehto J., Webster J. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282: 539–546, for the Systolic Hypertension in Europe (Syst-Eur) trial investigators[PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Svensson P., de Faire U., Sleight P., Yusuf S., Östergren J. Comparative effects of ramipril on ambulatory and office blood pressures. A HOPE substudy. Hypertension 2001; 38: e28–e32, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Touitou Y., Portaluppi F., Smolensky M. H., Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 2004; 21(1)161–170, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Verdecchia P., Porcellati C., Schillaci G., Borgioni C., Ciucci A., Battistell M., Guerrieri M., Gatteschi C., Zampi I., Santucci A., Santucci C., Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Witte K., Weisser K., Neubeck M., Mutschler E., Lehmann K., Hopf R., Lemmer B. Cardiovascular effects, pharmacokinetics and converting enzyme inhibition of enalapril after morning versus evening administration. Clin. Pharmacol. Ther. 1993; 54: 177–186, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar